3EO Health’s at-home COVID-19 testing device [Photo courtesy of 3EO Health}
The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test.Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device.
“In order to optimize the value of testing, tests should be simple to use, affordable, rapid, and accurate,” Yin said in a news release. “When it comes to COVID at-home tests, existing antigen tests lack sensitivity, and molecular tests are expensive. We have developed a simple and rapid test platform that promises to deliver PCR-level accuracy at antigen-level cost.”
3EO Health has a worldwide exclusive license agreement for the technology …